Zobrazeno 1 - 10
of 277
pro vyhledávání: '"R, MARAL"'
Trials in the treatment of the leukemias are sometimes based on a hypothesis, as in the case of exchange transfusion [33] or the use of antimetabolites [86]. Or they are conducted empirically as the results of chance observations, as in the case of t
Autor:
G, MOURIQUAND, R, MARAL
Publikováno v:
Journal de medecine de Lyon. 27
Publikováno v:
Journal de medecine de Lyon. 28(656)
Publikováno v:
Lyon medical. 177(22)
Publikováno v:
Mutation Research/Genetic Toxicology. 77:197-208
The antineoplastic drug daunorubicin and 15 other anthracyclines were tested for their ability to induce prophage λ in Escherichia coli K12. Prophage λ induction by daunorubicin was obtained in excision-repair deficient uvr − bacteria at doses ab
Autor:
R. Maral, G.H. Werner
Publikováno v:
Chemotherapy. 6:259-266
Publikováno v:
Biomedicine / [publiee pour l'A.A.I.C.I.G.]. 22(5)
Water-soluble substances have been extracted from two strains of Mycobacterium tuberculosis var. hominis: the native hydrosoluble part (polysaccharide and peptidoglycan), a substance in which the polysaccharide moiety is less abundant than in the lat
Autor:
G. Cueille, M. Marlard, Auclerc Mf, Auclerc G, Marise Weil, D. Heusse, F. Lavelle, Maral J, Jean Bernard, R. Maral, Claude Jacquillat
Publikováno v:
Recent Results in Cancer Research ISBN: 9783642814907
This report concerns the experimental activity and the preliminary clinical results obtained with detorubicin, an anthracycline. Experimentally, in comparison with doxorubicin, detorubicin is less toxic, less immunodepressive, and less mutagenic, its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a2ab3f9ba6ec8d05e34fa430b2e7c00
https://doi.org/10.1007/978-3-642-81488-4_22
https://doi.org/10.1007/978-3-642-81488-4_22
Publikováno v:
Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles. 278(6)
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 38(8)
Two batches of 110 females C57Bl mice were grafted with B 16 melanoma, the first batch at the age of 67 days, the second at 82 days. The animals were divided into groups of 10, and kept under a LD 12 : 12 regimen. The growth of the tumors was more ra